Form: POS AM

Post-effective amendment to a registration statement that is not immediately effective upon filing

October 8, 2024


Exhibit 23.2

Consent of Independent Registered Public Accounting Firm

We consent to the reference to our firm under the caption "Experts" and to the incorporation by reference of our report dated June 23, 2023, except for the effects of the reverse stock split described in Note 1, as to which the date is June 21, 2024, in amendment No.1 to Form S-4 (Form S-4 No. 333-280536) of Acasti Pharma Inc.
 
/s/ Ernst & Young LLP
 
   
Montréal, Canada
 
October 8, 2024